These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37741783)

  • 21. Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years.
    Sievert KD; Schonthaler M; Berges R; Toomey P; Drager D; Herlemann A; Miller F; Wetterauer U; Volkmer B; Gratzke C; Amend B
    World J Urol; 2019 Jul; 37(7):1353-1360. PubMed ID: 30283994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological and interventional treatment of benign prostatic obstruction: An evidence-based comparative review.
    Malde S; Lam W; Adwin Z; Hashim H
    BJUI Compass; 2021 Jul; 2(4):238-259. PubMed ID: 35475299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation.
    Nguyen DD; Li T; Ferreira R; Baker Berjaoui M; Nguyen AV; Chughtai B; Zorn KC; Bhojani N; Elterman D
    Prostate Cancer Prostatic Dis; 2024 Mar; 27(1):22-28. PubMed ID: 37081044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment Algorithm for Management of Benign Prostatic Obstruction: An Overview of Current Techniques.
    Hughes T; Harper P; Somani BK
    Life (Basel); 2023 Oct; 13(10):. PubMed ID: 37895457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of photoselective green light laser vaporisation versus traditional transurethral resection for benign prostate hyperplasia: an updated systematic review and meta-analysis of randomised controlled trials and prospective studies.
    Lai S; Peng P; Diao T; Hou H; Wang X; Zhang W; Liu M; Zhang Y; Seery S; Wang J
    BMJ Open; 2019 Aug; 9(8):e028855. PubMed ID: 31439603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostatic Urethral Lift for Obstructive Median Lobes: Consistent Results Across Controlled Trial and Real-World Settings.
    Eure G; Rukstalis D; Roehrborn C
    J Endourol; 2023 Jan; 37(1):50-59. PubMed ID: 35876440
    [No Abstract]   [Full Text] [Related]  

  • 27. Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH.
    Gilling PJ; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Kaufman RP; Badlani G; Plante M; Desai M; Doumanian L; Te AE; Roehrborn CG
    Can J Urol; 2022 Feb; 29(1):10960-10968. PubMed ID: 35150215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostatic Artery Embolisation Versus Transurethral Resection of the Prostate for Benign Prostatic Obstruction: 5-year Outcomes of a Randomised, Open-label, Noninferiority Trial.
    Müllhaupt G; Hechelhammer L; Graf N; Mordasini L; Schmid HP; Engeler DS; Abt D
    Eur Urol Focus; 2024 Sep; 10(5):788-795. PubMed ID: 38531756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Indirect Comparison of Newer Minimally Invasive Treatments for Benign Prostatic Hyperplasia: A Network Meta-Analysis Model.
    Tanneru K; Jazayeri SB; Alam MU; Kumar J; Bazargani S; Kuntz G; Palayapalayam Ganapathi H; Bandyk M; Marino R; Koochekpour S; Gautam S; Balaji KC; Costa J
    J Endourol; 2021 Apr; 35(4):409-416. PubMed ID: 32962442
    [No Abstract]   [Full Text] [Related]  

  • 30. Novel minimally invasive treatments for lower urinary tract symptoms: a systematic review and network meta-analysis.
    van Kollenburg RAA; van Riel LAMJG; de Bruin DM; de Rijke TM; Oddens JR
    Int Braz J Urol; 2023; 49(4):411-427. PubMed ID: 37267609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study.
    Sønksen J; Barber NJ; Speakman MJ; Berges R; Wetterauer U; Greene D; Sievert KD; Chapple CR; Montorsi F; Patterson JM; Fahrenkrug L; Schoenthaler M; Gratzke C
    Eur Urol; 2015 Oct; 68(4):643-52. PubMed ID: 25937539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second generation of temporary implantable nitinol device (iTind) in men with LUTS: 2 year results of the MT-02-study.
    Kadner G; Valerio M; Giannakis I; Manit A; Lumen N; Ho BSH; Alonso S; Schulman C; Barber N; Amparore D; Porpiglia F
    World J Urol; 2020 Dec; 38(12):3235-3244. PubMed ID: 32124019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Madersbacher S; Roehrborn CG; Oelke M
    BJU Int; 2020 Sep; 126(3):317-326. PubMed ID: 32599656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-inferiority, randomised, open-label clinical trial on the effectiveness of transurethral microwave thermotherapy compared to prostatic artery embolisation in reducing severe lower urinary tract symptoms in men with benign prostatic hyperplasia: study protocol for the TUMT-PAE-1 trial.
    Kristensen-Alvarez A; Fode M; Stroomberg HV; Nielsen KK; Arch A; Lönn LB; Taudorf M; Widecrantz SJ; Røder A
    Trials; 2024 Sep; 25(1):574. PubMed ID: 39223593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostatic artery embolization compared to transurethral resection of the prostate and prostatic urethral lift: a real-world population-based study.
    Raizenne BL; Zheng X; Oumedjbeur K; Mao J; Zorn KC; Elterman D; Bhojani N; McClure T; Te A; Kaplan S; Sedrakyan A; Chughtai B
    World J Urol; 2023 Jan; 41(1):179-188. PubMed ID: 36463348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up.
    Porpiglia F; Fiori C; Amparore D; Kadner G; Manit A; Valerio M; Nicolaas L; Ho BSH; Alonso S; Schulman C; Barber N
    BJU Int; 2019 Jun; 123(6):1061-1069. PubMed ID: 30382600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety Evaluation of Transurethral Resection of the Prostate versus Plasmakinetic Enucleation of the Prostate in the Treatment of Massive Benign Prostatic Hyperplasia.
    Zhang J; Wang Y; Li S; Jin S; Zhang S; Zhao C; Yang W; Cui S; Liu Y
    Urol Int; 2021; 105(9-10):735-742. PubMed ID: 33524981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia.
    Pattanaik S; Mavuduru RS; Panda A; Mathew JL; Agarwal MM; Hwang EC; Lyon JA; Singh SK; Mandal AK
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD010060. PubMed ID: 30480763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy and safety of prostatic urethral lift as a minimally invasive therapeutic modality to treat lower urinary tract symptoms while maintaining sexual function in patients with benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials.
    Warli SM; Ikram MF; Sarumpaet RG; Tala ZZ; Putrantyo II
    Arch Ital Urol Androl; 2024 Mar; 96(1):12066. PubMed ID: 38451253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging minimally invasive transurethral treatments for benign prostatic hyperplasia: a systematic review with meta-analysis of functional outcomes and description of complications.
    Manfredi C; Arcaniolo D; Spatafora P; Crocerossa F; Fusco F; Verze P; Fiori C; Damiano R; Cindolo L; DE Sio M; Otero JR
    Minerva Urol Nephrol; 2022 Aug; 74(4):389-399. PubMed ID: 34308611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.